Atlas Trials

Immunogenicity Study of the Recombinant Human Papillomavirus Virus Type 6/11 Bivalent Vaccine

Clinical trial NCT02710851 · UNKNOWN

Trial details

NCT number
NCT02710851
Sponsor
Jun Zhang
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Condylomata Acuminata
Start date
2016-03-24
Primary completion
2023-12-30
Enrollment
640

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.